Related Experiment Video

Updated: Jul 3, 2026

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
08:46

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo

Published on: January 26, 2024

Phage therapy experience at the Eliava Institute

M Kutateladze1, R Adamia

  • 1Eliava IBMV, 3, Gotua street, Tbilisi 0160, Georgia. kutateladze@pha.ge

Medecine Et Maladies Infectieuses
|August 9, 2008
PubMed

Insights

Multidrug resistant bacteria necessitate novel treatments. Bacteriophage therapy offers a promising alternative for infections unresponsive to antibiotics, as demonstrated by the Eliava Institute

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacteriophage Research

Background:

  • The rise of multidrug resistant bacterial strains poses a significant global health threat, diminishing the efficacy of conventional antibiotic therapies.
  • There is an urgent need for alternative treatment strategies to combat infections caused by antibiotic-resistant pathogens.

Purpose of the Study:

  • To review the Eliava Institute's extensive experience in applying bacteriophage therapy.
  • To highlight bacteriophage therapy as a viable alternative to antibiotics for treating challenging bacterial infections.

Main Methods:

  • Review of clinical case studies and research data from the Eliava Institute.
  • Analysis of treatment outcomes for various bacterial infections using phage preparations.

Main Results:

  • Bacteriophage therapy has shown effectiveness in treating a range of bacterial infections, including those resistant to antibiotics.
  • The Eliava Institute has a long-standing history and accumulated expertise in developing and utilizing phage preparations.

Conclusions:

  • Bacteriophage therapy represents a valuable and effective alternative or adjunctive treatment for multidrug resistant bacterial infections.
  • Continued research and application of phage therapy are crucial for addressing the challenge of antimicrobial resistance.

More Related Videos

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

Synthesis of Infectious Bacteriophages in an E. coli-based Cell-free Expression System11:33

Synthesis of Infectious Bacteriophages in an E. coli-based Cell-free Expression System

Published on: August 17, 2017

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.